Nasdaq:TCRX

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

December 26, 2024 07:00 ET  | Source: TScan Therapeutics, Inc. WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics,…

4 months ago